Download PDF
Klin Monbl Augenheilkd 2023; 240(02): 190-197
DOI: 10.1055/a-1998-9146
Statement

Empfehlungen bei progredienter Myopie im Kindes- und Jugendalter[*]

Stellungnahme von DOG, BVA und der Bielschowsky Gesellschaft für Schielforschung und Neuroophthalmologie. Stand Juni 2022Recommendations for Progressive Myopia in Childhood and Adolescence. Statement of the DOG, BVA and the Bielschowsky Society for Strabismus Research and NeuroophthalmologyStatus June 2022 Berufsverband der Augenärzte Deutschlands e. V. (BVA), Deutsche Ophthalmologische Gesellschaft (DOG), Bielschowsky Gesellschaft für Schielforschung und Neuroophthalmologie
› Further Information
Also available at
    Permissions and Reprints

Zusammenfassung

Seit der letzten und gleichzeitig ersten Stellungnahme der deutschen ophthalmologischen Fachgesellschaften zu den Möglichkeiten der Minderung von Myopieprogression im Kindes- und Jugendalter haben sich in der klinischen Forschung viele neue Details und Aspekte ergeben. Die nun vorliegende, zweite Stellungnahme aktualisiert das bisherige Dokuments und konkretisiert die Empfehlungen sowohl zum Seh- und Leseverhalten als auch zu den pharmakologischen und optischen Therapieoptionen, die in der Zwischenzeit sowohl verfeinert als auch neu entwickelt wurden.

Abstract

Since the last and at the same time first statement of the German ophthalmological societies on the possibilities of reducing myopia progression in childhood and adolescence, many new details and aspects have emerged in clinical research. This second statement updates the previous document and specifies the recommendations on visual and reading behavior as well as on pharmacological and optical therapy options, which have been both refined and newly developed in the meantime.

Schlüsselwörter

Kinder - Jugendliche - Myopie - Risikofaktor - Atropin - Kontaktlinsen - Multisegmentgläser

Key words

children - adolescents - myopia - risk factor - atropine - contact lenses - multisegment spectacles

* Diese Leitlinie erscheint ebenfalls in der Zeitschrift Die Ophthalmologie, Springer Verlag, Heidelberg. Das Redaktionskomitee dieser Stellungnahme wird am Beitragsende gelistet.




Publication History

Article published online:
22 February 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Wang CY, Hsu NW, Yang YC. et al. Premyopia at preschool age: population-based evidence of prevalence and risk factors from a serial survey in Taiwan. Ophthalmology 2022; 129: 880-889
    CrossrefPubMedSearch in Google Scholar
  • 2 Li SM, Wei S, Atchison DA. et al. Annual incidences and progressions of myopia and high myopia in Chinese schoolchildren based on a 5-year cohort study. Invest Ophthalmol Vis Sci 2022; 63: 8
    CrossrefPubMedSearch in Google Scholar
  • 3 Tsai TH, Liu YL, Ma IH. et al. Evolution of the prevalence of myopia among Taiwanese schoolchildren: a review of survey data from 1983 through 2017. Ophthalmology 2021; 128: 290-301
    CrossrefPubMedSearch in Google Scholar
  • 4 Williams KM, Verhoeven VJM, Cumberland P. et al. Prevalence of refractive error in europe: the European eye epidemiology (E(3)) consortium. Eur J Epidemiol 2015; 30: 305-315
    CrossrefPubMedSearch in Google Scholar
  • 5 Wesemann W. Analyse der Brillenstärken zeigt keine Zunahme der Myopie in Deutschland von 2000 bis 2015. Ophthalmologe 2018; 115: 409-417
    CrossrefPubMedSearch in Google Scholar
  • 6 Schuster AK, Krause L, Kuchenbäcker C. et al. Prävalenz von Kurzsichtigkeit und deren Veränderung bei Kindern und Jugendlichen. Dtsch Arztebl Int 2020; 117: 855-860
    CrossrefPubMedSearch in Google Scholar
  • 7 Schuster AK, Elflein HM, Pokora R. et al. Prävalenz und Risikofaktoren der Kurzsichtigkeit bei Kindern und Jugendlichen in Deutschland – Ergebnisse der KiGGS-Studie. Klin Padiatr 2017; 229: 234-240
    Thieme ConnectPubMedSearch in Google Scholar
  • 8 Truckenbrod C, Meigen C, Brandt M. et al. Longitudinal analysis of axial length growth in a German cohort of healthy children and adolescents. Ophthalmic Physiol Opt 2021; 41: 532-540
    CrossrefPubMedSearch in Google Scholar
  • 9 Tideman JWL, Snabel MCC, Tedja MS. et al. Association of axial length with risk of uncorrectable visual impairment for europeans with myopia. JAMA Ophthalmol 2016; 134: 1355-1363
    CrossrefPubMedSearch in Google Scholar
  • 10 Curtin BJ, Karlin DB. Axial length measurements and fundus changes of the myopic eye. I. The posterior fundus. Trans Am Ophthalmol Soc 1970; 68: 312-334
    PubMedSearch in Google Scholar
  • 11 Daien V, Le Pape A, Heve D. et al. Incidence and characteristics of cataract surgery in France from 2009 to 2012: a national population study. Ophthalmology 2015; 122: 1633-1638
    CrossrefPubMedSearch in Google Scholar
  • 12 Gerstenberger E, Stoffelns B, Nickels S. et al. Incidence of retinal detachment in Germany: results from the Gutenberg health study. Ophthalmologica 2021; 244: 133-140
    CrossrefPubMedSearch in Google Scholar
  • 13 Enthoven CA, Tideman JWL, Polling JR. et al. Interaction between lifestyle and genetic susceptibility in myopia: the generation R study. Eur J Epidemiol 2019; 34: 777-784
    CrossrefPubMedSearch in Google Scholar
  • 14 Ghorbani Mojarrad N, Williams C, Guggenheim JA. A genetic risk score and number of myopic parents independently predict myopia. Ophthalmic Physiol Opt 2018; 38: 492-502
    CrossrefPubMedSearch in Google Scholar
  • 15 Mirshahi A, Ponto KA, Hoehn R. et al. Myopia and level of education: results from the Gutenberg health study. Ophthalmology 2014; 121: 2047-2052
    CrossrefPubMedSearch in Google Scholar
  • 16 Gwiazda J, Deng L, Manny R. COMET Study Group. Seasonal variations in the progression of myopia in children enrolled in the correction of myopia evaluation trial. Invest Ophthalmol Vis Sci 2014; 55: 752-758
    CrossrefPubMedSearch in Google Scholar
  • 17 Picotti C, Sanchez V, Fernandez Irigaray L. et al. Rapid progression of myopia at onset during home confinement. J AAPOS 2022; 26: 65.e1-65.e4
    CrossrefPubMedSearch in Google Scholar
  • 18 Wong CW, Tsai A, Jonas JB. et al. Digital screen time during the COVID-19 pandemic: risk for a further myopia boom?. Am J Ophthalmol 2021; 223: 333-337
    CrossrefPubMedSearch in Google Scholar
  • 19 Muralidharan AR, Lança C, Biswas S. et al. Light and myopia: from epidemiological studies to neurobiological mechanisms. Ther Adv Ophthalmol 2021; 13
    CrossrefPubMedSearch in Google Scholar
  • 20 Gajjar S, Ostrin LA. A systematic review of near work and myopia: measurement, relationships, mechanisms and clinical corollaries. Acta Ophthalmol 2021; 100: 376-387
    CrossrefPubMedSearch in Google Scholar
  • 21 Hughes RPJ, Read SA, Collins MJ. et al. Axial elongation during short-term accommodation in myopic and nonmyopic children. Invest Ophthalmol Vis Sci 2022; 63: 12
    CrossrefPubMedSearch in Google Scholar
  • 22 Yang YC, Hsu NW, Wang CY. et al. Prevalence trend of myopia after promoting eye care in preschoolers: a serial survey in Taiwan before and during the Coronavirus disease 2019 pandemic. Ophthalmology 2022; 129: 181-190
    CrossrefPubMedSearch in Google Scholar
  • 23 Pineles SL, Kraker RT, VanderVeen DK. et al. Atropine for the prevention of myopia progression in children: a report by the American academy of ophthalmology. Ophthalmology 2017; 124: 1857-1866
    CrossrefPubMedSearch in Google Scholar
  • 24 Huang J, Wen D, Wang Q. et al. Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis. Ophthalmology 2016; 123: 697-708
    CrossrefPubMedSearch in Google Scholar
  • 25 Walline JJ, Lindsley KB, Vedula SS. et al. Interventions to slow progression of myopia in children. Cochrane Database Syst Rev 2020; (01) CD4916
    PubMedSearch in Google Scholar
  • 26 Moriche-Carretero M, Revilla-Amores R, Diaz-Valle D. et al. Myopia progression and axial elongation in Spanish children: efficacy of atropine 0.01 % eye-drops. J Fr Ophtalmol 2021; 44: 1499-1504
    CrossrefPubMedSearch in Google Scholar
  • 27 Lee SSY, Mackey DA, Lingham G. et al. Western Australia atropine for the treatment of myopia (WA-ATOM) study: rationale, methodology and participant baseline characteristics. Clin Experiment Ophthalmol 2020; 48: 569-579
    CrossrefPubMedSearch in Google Scholar
  • 28 Azuara-Blanco A, Logan N, Strang N. et al. Low-dose (0.01 %) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)-study protocol. Br J Ophthalmol 2020; 104: 950-955
    CrossrefPubMedSearch in Google Scholar
  • 29 Chia A, Chua WH, Cheung YB. et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5 %, 0.1 %, and 0.01 % doses (atropine for the treatment of myopia 2). Ophthalmology 2012; 119: 347-354
    CrossrefPubMedSearch in Google Scholar
  • 30 Yam JC, Jiang Y, Tang SM. et al. Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05 %, 0.025 %, and 0.01 % atropine eye drops in myopia control. Ophthalmology 2019; 126: 113-124
    CrossrefPubMedSearch in Google Scholar
  • 31 Yam JC, Li FF, Zhang X. et al. Two-year clinical trial of the low-concentration atropine for myopia progression (LAMP) study: phase 2 report. Ophthalmology 2020; 127: 910-919
    CrossrefPubMedSearch in Google Scholar
  • 32 Wei S, Li SM, An W. et al. Safety and efficacy of low-dose atropine eyedrops for the treatment of myopia progression in Chinese children: a randomized clinical trial. JAMA Ophthalmol 2020; 138: 1178-1184
    CrossrefPubMedSearch in Google Scholar
  • 33 Polling JR, Tan E, Driessen S. et al. A 3-year follow-up study of atropine treatment for progressive myopia in Europeans. Eye (Lond) 2020; 34: 2020-2028
    CrossrefPubMedSearch in Google Scholar
  • 34 Wang YR, Bian HL, Wang Q. Atropine 0.5 % eyedrops for the treatment of children with low myopia: a randomized controlled trial. Medicine 2017; 96: e7371
    CrossrefPubMedSearch in Google Scholar
  • 35 Joachimsen L, Farassat N, Bleul T. et al. Side effects of topical atropine 0.05 % compared to 0.01 % for myopia control in German school children: a pilot study. Int Ophthalmol 2021; 41: 2001-2008
    CrossrefPubMedSearch in Google Scholar
  • 36 Austermann H, Schaeffel F, Mathis U. et al. Corneal penetration of low-dose atropine eye drops. J Clin Med 2021; 10: 588
    CrossrefPubMedSearch in Google Scholar
  • 37 Fu A, Stapleton F, Wei L. et al. Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression. Br J Ophthalmol 2020; 104: 1535-1541
    PubMedSearch in Google Scholar
  • 38 Joachimsen L, Böhringer D, Gross NJ. et al. A pilot study on the efficacy and safety of 0.01 % atropine in German schoolchildren with progressive myopia. Ophthalmol Ther 2019; 8: 427-433
    CrossrefPubMedSearch in Google Scholar
  • 39 Hieda O, Hiraoka T, Fujikado T. et al. Efficacy and safety of 0.01 % atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study. Jpn J Ophthalmol 2021; 65: 315-325
    CrossrefPubMedSearch in Google Scholar
  • 40 Ha A, Kim SJ, Shim SR. et al. Efficacy and safety of 8 atropine concentrations for myopia control in children: a network meta-analysis. Ophthalmology 2022; 129: 322-333
    CrossrefPubMedSearch in Google Scholar
  • 41 Chen C, Yao J. Efficacy and adverse effects of atropine for myopia control in children: a meta-analysis of randomised controlled trials. J Ophthalmol 2021;
    CrossrefPubMedSearch in Google Scholar
  • 42 Yu Z, Zhong A, Zhao X. et al. Efficacy and safety of different add power soft contact lenses on myopia progression in children: a systematic review and meta-analysis. Ophthalmic Res 2022;
    CrossrefPubMedSearch in Google Scholar
  • 43 Chamberlain P, Peixoto-de-Matos SC, Logan NS. et al. 3-year randomized clinical trial of misight lenses for myopia control. Optom Vis Sci 2019; 96: 556-567
    CrossrefPubMedSearch in Google Scholar
  • 44 Queirós A, Amorim-de-Sousa A, Lopes-Ferreira D. et al. Relative peripheral refraction across 4 meridians after orthokeratology and LASIK surgery. Eye Vis 2018; 5: 12
    CrossrefPubMedSearch in Google Scholar
  • 45 Cho P, Cheung SW. Retardation of myopia in orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci 2012; 53: 7077-7085
    CrossrefPubMedSearch in Google Scholar
  • 46 Sankaridurg P, Bakaraju RC, Naduvilath T. et al. Myopia control with novel central and peripheral plus contact lenses and extended depth of focus contact lenses: 2 year results from a randomised clinical trial. Ophthalmic Physiol Opt 2019; 39: 294-307
    CrossrefPubMedSearch in Google Scholar
  • 47 Huang Y, Li X, Ding C. et al. Comparison of peripheral refraction and higher-order aberrations between orthokeratology and multifocal soft contact lens designed with highly addition. Graefes Arch Clin Exp Ophthalmol 2022; 260: 1755-1762
    CrossrefPubMedSearch in Google Scholar
  • 48 Sun L, Li ZX, Chen Y. et al. The effect of orthokeratology treatment zone decentration on myopia progression. BMC Ophthalmol 2022; 22: 76
    CrossrefPubMedSearch in Google Scholar
  • 49 Lam CS, Tang WC, Lee PH. et al. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. Br J Ophthalmol 2022; 106: 1110-1114
    CrossrefPubMedSearch in Google Scholar
  • 50 Bao J, Huang Y, Li X. et al. Spectacle lenses with aspherical lenslets for myopia control vs. single-vision spectacle lenses: a randomized clinical trial. JAMA Ophthalmol 2022; 140: 472-478
    CrossrefPubMedSearch in Google Scholar
  • 51 Lam CSY, Tang WC, Qi H. et al. Effect of defocus incorporated multiple segments spectacle lens wear on visual function in myopic Chinese children. Transl Vis Sci Technol 2020; 9: 11
    CrossrefPubMedSearch in Google Scholar
  • 52 Kaymak H, Graff B, Neller K. et al. Myopietherapie und Prophylaxe mit “Defocus Incorporated Multiple Segments”-Brillengläsern. Ophthalmologe 2021; 118: 1280-1286
    CrossrefPubMedSearch in Google Scholar
  • 53 Gao C, Wan S, Zhang Y. et al. The efficacy of atropine combined with orthokeratology in slowing axial elongation of myopia children: a meta-analysis. Eye Contact Lens 2021; 47: 98-103
    CrossrefPubMedSearch in Google Scholar